Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - CASH & EQUIVALENTS
Cash & Equivalents CRVS - Corvus Pharmaceuticals, Inc.
12.6 M
LAST VALUE
-55.40%
2 YEAR CAGR
-35.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR